Oncology
Oncology
Advertisement
Rob DillardESMO Breast Cancer 2024 | May 16, 2024
The HER2DX ERBB2 mRNA score was significantly associated with improved survival in patients with metastatic HER2+ BC.
Read More
Rob DillardESMO Breast Cancer 2024 | May 16, 2024
Breast cancer survivors with metabolic syndrome have shorter disease-free survival than those without metabolic syndrome.
Rob DillardESMO Breast Cancer 2024 | May 15, 2024
Breast cancer survivors have a modestly increased risk of type 2 diabetes, largely driven by breast cancer treatment.
Rob DillardESMO Breast Cancer 2024 | May 15, 2024
Using the HER2DX genomic tool is feasible in a real-world setting of patients with early-stage HER2-positive breast cancer.
Rob DillardESMO Breast Cancer 2024 | May 15, 2024
Patients with breast cancer who have high levels of glycosylated hemoglobin have an increased risk of recurrence and death.
Rob DillardESMO Breast Cancer 2024 | May 15, 2024
Breast cancer patients have an increased risk of cardiovascular disease compared with the general female population.
Chadi Nabhan, MD, MBAHealthcare Unfiltered | May 14, 2024
Dr. Chadi Nabhan sits down with Dr. Chandana Banerjee, a trailblazer in palliative and hospice care.
Rob DillardCervical Cancer | May 14, 2024
Camrelizumab plus apatinib demonstrates robust and sustained efficacy in treating patients with advanced cervical cancer.
Rob DillardBreast Cancer | May 13, 2024
Women with more metabolic syndrome components face a higher risk of dying from breast cancer.
Rob DillardSkin Cancer | May 9, 2024
A new survey showed that too many young people believe myths and misinformation related to skin cancer prevention.
Rob DillardGynecologic Cancer | May 3, 2024
The FDA granted approval to tisotumab vedotin-tftv for the treatment of recurrent or metastatic cervical cancer.
Chadi Nabhan, MD, MBAHealthcare Unfiltered | April 30, 2024
Drs. Nabhan and Ahluwalia delve into the latest breakthroughs in primary brain cancers.
Mary GreccoLung Cancer | April 30, 2024
A study that examined whether the combination of AI and knowledge can identify more patients with lung and ovarian cancers.
Rob DillardHead and Neck Cancer | April 29, 2024
A gene model has the potential to serve as a prognostic indicator for patients with head and neck squamous cell carcinoma.
Mary GreccoLung Cancer | April 25, 2024
A study examined whether AI and clinical knowledge can identify more patients with lung and ovarian cancers.
Rob DillardGynecologic Cancer | April 24, 2024
The addition of dostarlimab to platinum chemotherapy is cost effective and significantly improves QOL.
Dr. Timothy YapBreast Cancer | April 22, 2024
Dr. Timothy Yap discusses the PETRA trial, which showed the efficacy of saruparib in treating HER2-negative breast cancer.
Rob DillardBreast Cancer | April 15, 2024
Soft tumor environments can cause triple-negative breast cancer to spread more aggressively.
Darwin KwokOncology | April 15, 2024
Darwin Kwok discusses how he felt about winning the award and what he’s learned from past recipients.
Rob DillardHead and Neck Cancer | April 12, 2024
The use of a 3D variable flip angle mapping technique is effective in patients with head and neck cancer undergoing CRT.
Advertisement
Advertisement
Advertisement
Latest News

May 17, 2024